Nevertheless, since lung inflammation can promote lung remodeling and RV hypertrophy without affecting LV function in mice with pre-existing HF (24) and since IL12β can regulate the inflammatory response, pharmacological inhibition of IL12β may directly reduce lung inflammation and remodeling in HF mice. The gene discussed is IL12B; the disease is inflammation.